References
- Tribukait B. Flow cytometry in assessing the clinical aggressiveness of genito-urinary neoplasms. World J Urol 1987; 5: 108–22
- Hedlund P O, Adolfsson J, Rönnström L, Tribukait B. Modal DNA as prognostic indicator in untreated prostatic cancer. Scand J Urol Nephrol 1988; 22: 125–9, Suppl 110
- Björk P, Forsgren B, Gustafsson J-Å, Pousette Å, Högberg B. Partial characterization and 'quantitation' of a human estramustine-binding protein. Cancer Res 1982; 42: 1935–42
- Nilsson S, Nordgren H, Karlberg L, et al. Expression of estramustine-binding protein (EMBP) and the proliferation-associated antigen Ki-67 in prostatic carcinomas. Scand J Urol Nephrol 1988; 22(Suppl 110)31–7
- Bergh J, Björk P, Westlin J-E, Nilsson S. Expression of an estramustine-binding associated protein in human lung cancer cell lines. Cancer Res 1988; 48: 4615–19
- Hsu S, Raine L, Fanger H. Use of avidin-biotin-peroxidase comples (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577–80
- Tribukait B. Flow cytometry in surgical pathology and cytology of tumours of the genito-urinary tract, L G Koss, D V Coleman. Adv Clin Cytology. 1984; 2: 163–89